Evidence map›Paper›PMID 31858662›Full record

SynthesisHealth expectations : an international journal of public participation in health care and health policy2020

Financial relationships between patient and consumer representatives and the health industry: A systematic review.

Joanne Khabsa, Aline Semaan, Amena El-Harakeh, Assem M Khamis, Serena Obeid, Hussein A Noureldine, Elie A Akl

Abstract readSystematic Review
In one paragraph

Synthesis in Health expectations : an international journal of public participation in health care and health policy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pharmaceutical policies: effects of policies regulating drug marketing.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Financial relationships between patient and consumer representatives and the health industry: A systematic review.Health expectations : an international journal of public participation in health care and health policy · 2020
    Pooled it
  3. Review
  4. Article
  5. Article
  6. Ethical challenges in contemporary psychiatry: an overview and an appraisal of possible strategies and research needs.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Joanne KhabsaClinical Research Institute, American University of Beirut Medical Center, Beirut, Lebanon.ORCID 0000-0002-4336-3501
Aline SemaanCenter for Research on Population and Health, American University of Beirut, Beirut, Lebanon.
Amena El-HarakehClinical Research Institute, American University of Beirut Medical Center, Beirut, Lebanon.
Assem M KhamisClinical Research Institute, American University of Beirut Medical Center, Beirut, Lebanon.ORCID 0000-0002-5567-7065
Serena ObeidFaculty of Arts and Sciences, American University of Beirut, Beirut, Lebanon.
Hussein A NoureldineFaculty of Medicine, Lebanese American University, Byblos, Lebanon.ORCID 0000-0002-8547-2191
Elie A AklDepartment of Internal Medicine, American University of Beirut, Beirut, Lebanon.ORCID 0000-0002-3444-8618

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients and consumers are increasingly engaged in health policymaking, research and drug regulation. Having financial relationships with the health industry creates situations of conflicts of interest (COI) and might compromise their meaningful and unbiased participation.

objectiveTo synthesize available evidence on the financial relationships between the health industry and patient and consumer representatives and their organizations.

methodsWe systematically searched MEDLINE and EMBASE. We selected studies and abstracted data in duplicate and independently. We reported on outcomes related to financial relationships of individuals with, and/or funding of organizations by the health industry.

resultsWe identified a total of 14 510 unique citations, of which 24 reports of 23 studies were eligible. Three studies (13%) addressed the financial relationship of patient and consumer representatives with the health industry. Of these, two examined the proportion of public speakers in drug regulatory processes who have financial relationships; the proportions in the two studies were 25% and 19% respectively. Twenty studies (87%) addressed funding of patient and consumer organizations. The median proportion of organizations that reported funding from the health industry was 62% (IQR: 34%-69%) in questionnaire surveys, and 75% (IQR: 58%-85%) in surveys of their websites. Among organizations for which there was evidence of industry funding, a median proportion of 29% (IQR: 27%-44%) acknowledged on their websites receiving that funding.

conclusionFinancial relationships between the health industry and patient and consumer representatives and their organizations are common and may not be disclosed. Stricter regulation on disclosure and management is needed.

Indexed as

DisclosureDrug IndustryConflict of InterestConsumer OrganizationsHumansPolicy Makingconflict of interestconsumerfundingpatient representativessystematic review

Identifiers

PMID31858662
PMCPMC7104632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.